(Q34656760)

3 August 2017

1 reference

title

Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis (English)

1 reference

3 August 2017

0 references

0 references

2

Jean-Yves Reginster

1 reference

3 August 2017

1

Olivier Bruyere

1 reference

3 August 2017

publication date

1 January 2007

1 reference

3 August 2017

1 reference

3 August 2017

volume

24

1 reference

3 August 2017

issue

7

1 reference

3 August 2017

page(s)

573-580

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-200724070-00005

3 August 2017

exact match

0 references

cites work

Prevalence and impact of osteoarthritis and osteoporosis on health-related quality of life among active subjects.

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00002512-200724070-00005

Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinically relevant doses

21 January 2018

1 reference

12 December 2020

Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study

1 reference

12 December 2020

Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial

1 reference

12 December 2020

Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis

1 reference

12 December 2020

Clinical trials in osteoarthritis

1 reference

12 December 2020

EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)

1 reference

12 December 2020

Osteoarthritis as a public health problem: the impact of developing knee pain on physical function in adults living in the community: (KNEST 3).

1 reference

12 December 2020

Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator

1 reference

12 December 2020

Comparison of the antiinflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis

1 reference

12 December 2020

Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3 x 400 mg/day vs placebo

1 reference

12 December 2020

Sulfate could mediate the therapeutic effect of glucosamine sulfate

1 reference

12 December 2020

Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study.

1 reference

12 December 2020

Chondroitin sulfate and other sulfate containing chondroprotective agents may exhibit their effects by overcoming a deficiency of sulfur amino acids

1 reference

12 December 2020

Chondroitin sulfate in osteoarthritis of the knee: a prospective, double blind, placebo controlled multicenter clinical study

1 reference

12 December 2020

Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee

1 reference

12 December 2020

OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited.

1 reference

12 December 2020

Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee

1 reference

12 December 2020

Guidelines for testing slow acting drugs in osteoarthritis.

1 reference

12 December 2020

Commentary: osteoarthritis of the knee and glucosamine

1 reference

12 December 2020

Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with knee osteoarthritis.

1 reference

12 December 2020

Risk assessment for glucosamine and chondroitin sulfate

1 reference

12 December 2020

Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo

1 reference

12 December 2020

Conducting clinical trials over the internet: feasibility study.

1 reference

12 December 2020

A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis.

1 reference

12 December 2020

Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis

1 reference

12 December 2020

Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial

1 reference

12 December 2020

Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis.

1 reference

12 December 2020

Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis

1 reference

12 December 2020

Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis

1 reference

12 December 2020

Glucosamine therapy for treating osteoarthritis

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis.

1 reference

12 December 2020

Effectiveness of glucosamine for symptoms of knee osteoarthritis: results from an internet-based randomized double-blind controlled trial.

1 reference

12 December 2020

Active ingredient consistency of commercially available glucosamine sulfate products

1 reference

12 December 2020

Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis.

1 reference

12 December 2020

10.2165/00002512-200724070-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

1041888649

0 references

1 reference